Kiniksa Pharmaceuticals L... (KNSA)
NASDAQ: KNSA
· Real-Time Price · USD
27.81
-0.60 (-2.11%)
At close: Jun 17, 2025, 12:20 PM
13F Institute Ownership
Total Institutes of 164 in Kiniksa Pharmaceuticals reduced their positions with a decrease of 18 investors compared to the previous quarter. A reduction of 592.07K shares, as total invested capital declined by $218.25M with ownership percentage dropping from 55.25% to 54.66%.
Options Activity
Institutions are holding Calls/Puts contracts nearly balanced, indicating a neutral sentiment.
Put/Call 1.033
1.03
Call Flow 118,000
49%
Put Flow 121,900
51%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Blackrock, Inc. | 5.00% | 3.57M | -6.43% | 70.65M | < 0.01% |
| Braidwell LP | 4.83% | 3.45M | +19.28% | 68.29M | 2.02% |
| Vanguard Group Inc | 4.49% | 3.21M | -2.75% | 63.44M | < 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.